prodrugs - Globe Thesis

Keyword [prodrugs] Result: 81 - 100 \| Page: 5 of 6
81.	Novel targeted lipid prodrugs to improve cellular absorption of acyclovir and topical delivery to the eye via nanomicellar approach
82.	Designing anticancer prodrugs for targeting drug transporters and activating enzymes
83.	Biological evaluation of mitochondria-targeting photosensitizers and site-specific prodrugs
84.	Synthesis and Biological Evaluation of N-2' Derived Emetine Analogs and pH-Activatable Prodrugs as Potential Chemotherapy for Prostate Cancer
85.	Bioevasive prodrugs: Identification and evasion of nucleoside-metabolizing enzymes
86.	NSAID Prodrugs with Improved Anti-inflammatory Activity and Low Ulcerogenicity: Wake Up Call to Pharmaceutical Companies and Health Authorities
87.	Synthesis of combretastatin A-2 prodrugs and cephalostatin 1 structural modifications
88.	Activation of anticancer prodrugs by human carboxylesterases
89.	Design of prodrugs of acyclovir for ocular, oral and genital herpes virus infections: Targeting the oligopeptide and amino acid transporter on the cornea and intestine for improved bioavailability, safety and therapeutic activity
90.	Design, synthesis, and evaluation of potent androgen receptor targeted prodrugs of doxorubicin
91.	Integration of preclinical and clinical data with pharmacokinetic modeling and simulations to characterize the disposition of orally-active antiparasitic prodrugs and metabolites: Prediction of the dose-exposure relationship in humans
92.	The design, synthesis, mechanisms of activation and biological activity of indolequinone phosphoramidate prodrugs
93.	Cyclic prodrugs of a model opioid peptide for brain delivery
94.	Enhanced oral delivery of hydrophilic drugs: Design and evaluation of tight junction modulators and cyclic peptide prodrugs
95.	Synthesis of potential anti-HIV agents and prodrugs: Part I synthesis of L-3'-hydroxymethylnucleosides. Part II synthesis and pharmacokinetics of 3'-azido-2',3'-dideoxyuridine (AZDU) as prodrugs
96.	An investigation of the purported vasodilation mechanisms of nitroglycerin and nitric oxide prodrugs
97.	Development of novel carriers, prodrugs, and liposomes for molecular transport
98.	Stereoisomeric prodrugs to improve ocular and oral absorption of prednisolone
99.	Development of macromolecular prodrugs for improved treatment of lupus nephritis
100.	Glucuronidase Immobilized in Nanoparticles for Use in Site Specific Activation of Anti-Cancer Glucuronide Prodrugs
<<First <Prev Next> Last>> Jump to